By targeting these pathways together, early research suggests retatrutide may offer enhanced benefits for weight loss and blood sugar control compared to existing single- or dual-agonist medications
Retatrutide is currently investigational and is not widely approved for routine clinical use
[DOI] [PubMed] [Google Scholar] [116].Pfeffer MA, Claggett B, Diaz R, et al
Diabetic retinopathy complications: rapid improvement in glycemic control may worsen diabetic retinopathy acutely
You have worked hard to feel stronger, healthier, and more confident in your body, and you deserve for your reflection to mirror that same sense of pride and accomplishment
Assuming both drugs are similarly efficacious, there is a clear incentive for the manufacturer to raise the list price in order to provide a higher rebate while only having a marginally lower net price than its competitor